Anti-angiogenic Effects of Electroacupuncture in Endometriosis: Role of the TGF-β/Smad/VEGF Axis

Chunming Yan, Maria Begoña Criado, Jorge Pereira Machado
2026 · doi:10.5281/zenodo.20156178 · W7160998211
article OA: green CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-17 ⓘ

Electroacupuncture treatment of endometriosis in rats reduced pain and lesion size by downregulating TGF-β1, Smad2, Smad3, MMP2, MMP9, and VEGF-A expression.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objective: To evaluate the therapeutic efficacy of electroacupuncture (EA) at the Guanyuan (CV4), Qihai (CV6), and Zigong (EX-CA1) points in a rat model of endometriosis (EMs), and to elucidate its regulatory effects on the TGF-β/Smad signalling pathway and associated angiogenic factors.Methods: An EMs model was established in 30 female Sprague-Dawley rats via autotransplanta-tion. Rats were randomly assigned to three groups (n=10 each): Model, Gestrinone, and EA. The EA group received daily treatment at CV4, CV6, and EX-CA1 (2–100 Hz, 0.3–0.6 mA, 20 min) for 14 consecutive days. Therapeutic outcomes were assessed via writhing response latency and frequency, ectopic lesion volume, and histopathological analysis. The protein expression of TGF-β1, Smad2, Smad3, MMP2, MMP9, and VEGF-A was quantified using Western blot and im-munofluorescence.Results: Compared to the model group, EA significantly prolonged writhing latency and re-duced both the writhing score and ectopic tissue volume (all P < 0.01). Histopathological analysis of the model group revealed flattened, shed, or absent epithelium with a reduced glandular count. Molecular analysis demonstrated that EA treatment significantly downregulated the ex-pression of TGF-β1, Smad2, Smad3, MMP2, MMP9, and VEGF-A compared to the model group (all P < 0.05).Conclusion: EA effectively alleviates dysmenorrhea-like symptoms and inhibits the growth of ectopic endometrial lesions in rats. This therapeutic effect is likely mediated by the inhibition of the TGF-β/Smad signalling pathway, which subsequently suppresses MMP and VEGF expression to prevent pathological angiogenesis.
Full text 2,230 characters · extracted from oa-doi-fallback · 4 sections · click to expand

Objective

To evaluate the therapeutic efficacy of electroacupuncture (EA) at the Guanyuan (CV4), Qihai (CV6), and Zigong (EX-CA1) points in a rat model of endometriosis (EMs), and to elucidate its regulatory effects on the TGF-β/Smad signalling pathway and associated angiogenic factors.

Methods

An EMs model was established in 30 female Sprague-Dawley rats via autotransplanta-tion. Rats were randomly assigned to three groups (n=10 each): Model, Gestrinone, and EA. The EA group received daily treatment at CV4, CV6, and EX-CA1 (2–100 Hz, 0.3–0.6 mA, 20 min) for 14 consecutive days. Therapeutic outcomes were assessed via writhing response latency and frequency, ectopic lesion volume, and histopathological analysis. The protein expression of TGF-β1, Smad2, Smad3, MMP2, MMP9, and VEGF-A was quantified using Western blot and im-munofluorescence.

Results

Compared to the model group, EA significantly prolonged writhing latency and re-duced both the writhing score and ectopic tissue volume (all P < 0.01). Histopathological analysis of the model group revealed flattened, shed, or absent epithelium with a reduced glandular count. Molecular analysis demonstrated that EA treatment significantly downregulated the ex-pression of TGF-β1, Smad2, Smad3, MMP2, MMP9, and VEGF-A compared to the model group (all P < 0.05).

Conclusion

EA effectively alleviates dysmenorrhea-like symptoms and inhibits the growth of ectopic endometrial lesions in rats. This therapeutic effect is likely mediated by the inhibition of the TGF-β/Smad signalling pathway, which subsequently suppresses MMP and VEGF expression to prevent pathological angiogenesis. Files 022026.pdf Files (1.5 MB) | Name | Size | Download all | |---|---|---| | md5:46528f687caf53c07b981b990bc0a6c4 | 1.5 MB | Preview Download |

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisdysmenorrhea

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-08-12T06:00:24.528921+00:00
License: CC0 · commercial use OK